Shuichi Mitsunaga

7PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Sport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2026
Potent antitumor efficacy of datopotamab deruxtecan compared with sacituzumab govitecan in an intracranial tumor model of triple-negative breast cancer.

|Oct 01, 2025
Near-Infrared Photoimmunotherapy Targeting Esophagogastric Junction Adenocarcinoma With Fully Human Anti-EpCAM Antibody.

Maasa Sasabe, Kenji Takashima, Shingo Sakashita

|Jun 16, 2025
A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO).

Shuichi Mitsunaga, Tateaki Naito, Hisao Imai

|Sep 25, 2024
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1).

Shuichi Mitsunaga, Masafumi Ikeda, Shogo Nomura

|Jun 20, 2024
Identification of a urinary CD276 fragment for detecting resectable pancreatic cancer using a C-terminal proteomics strategy.

Shuichi Mitsunaga, Nobuaki Okumura, Toshiki Takei

|Aug 22, 2023
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.

Shuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka

Pageof 2

Frequent Collaborators

2 joint publications

Masahiro Yasunaga

1 joint publications

Masafumi Ikeda

1 joint publications

Kazuo Watanabe

1 joint publications

Kazunori Aoki